Objective: To assess oncological and ophthalmological outcomes after international referral of uveal melanoma patients for proton therapy.
Materials And Methods: This is a retrospective study among Dutch uveal melanoma patients who were treated in Switzerland with 60.0 CGE proton therapy (in 4 fractions) from 1987 to 2019.